| Literature DB >> 21088504 |
Paolo Zanotti-Fregonara1, Isabelle Keller, Marie Calzada-Nocaudie, Adil Al-Nahhas, Jean-Yves Devaux, Gaia Grassetto, Maria Cristina Marzola, Domenico Rubello, Elif Hindié.
Abstract
After thyroidectomy and 131I ablation for differentiated thyroid cancer (DTC), serum thyroglobulin (Tg) became a sensitive marker of residual disease. It is not uncommon to find patients at follow-up with persistent serum Tg levels and no other clinical or imaging evidence for the disease. The vast majority of these patients, most probably, have occult foci of disease, often in minute cervical lymph nodes. A review of the literature including papers published on PubMed/Medline until June 2010 was made. In this study we speculated that a minority of patients who had undergone surgery for differentiated thyroid cancer might have benign sources of Tg secretion at follow-up. These sources may be foci of radio-resistant ectopic thyroid tissue or a thyroid stimulating hormone-stimulated thymus.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21088504 DOI: 10.1097/MNM.0b013e328340e717
Source DB: PubMed Journal: Nucl Med Commun ISSN: 0143-3636 Impact factor: 1.690